| 摘要 |
The present invention relates to a method for predicting and/or diagnosing neoplastic transformation in a patient infected with HCV, wherein said method comprises the determination of the presence or absence of integration of HCV into the genome of host cells taken from said patient, and wherein the presence of HCV integration is used to identify the patient as being at high risk for developing or already having developed and HCV-related neoplastic condition.
|
